microRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by base pairing with their target messenger RNAs. Dysregulation of miRNAs is involved in the pathological initiation and progression of many human diseases. miR-221 and miR-222 (miR-221/222) are two highly homologous miRNAs, and they are significantly overexpressed in several types of human diseases. Silencing miR-221/222 could represent a promising approach for therapeutic studies. In the present review, we will describe the potential value of miR-221/222 as diagnostic, prognostic, and therapeutic biomarkers in various diseases including cancer and inflammatory diseases.
CITATION STYLE
Song, J., Ouyang, Y., Che, J., Li, X., Zhao, Y., Yang, K., … Yuan, W. (2017, February 16). Potential value of miR-221/222 as diagnostic, prognostic, and therapeutic biomarkers for diseases. Frontiers in Immunology. Frontiers Research Foundation. https://doi.org/10.3389/fimmu.2017.00056
Mendeley helps you to discover research relevant for your work.